Understanding Bowel Cancer Family History: Key Risk Factors and Early Screening Explained

August 13, 2026
Written by
Dr. Steven Lu
Chief Medical Officer | MBBS (hons) | DCH FRACGP
Medically reviewed by
Dr. Stephanie Bishop
Preventative Medicine & Gut Health Doctor | MBBS (Hons)
Understanding Bowel Cancer Family History: Key Risk Factors and Early Screening Explained

Bowel cancer family history is one of the strongest known risk factors for developing bowel cancer, especially when a first-degree relative, a parent, sibling or child, has been diagnosed. Around 20 to 30 per cent of bowel cancer cases involve a family history, and a smaller share are linked to inherited conditions such as Lynch syndrome and familial adenomatous polyposis (FAP) (Bowel Cancer Australia, 2024; National Cancer Institute, 2025). If you have a family history, Everlab will help you to understand your personal risk and screening timeline.

Key facts

  • Family history is linked to an estimated 20 to 30 per cent of bowel cancer cases (Bowel Cancer Australia, 2024).
  • Having one first-degree relative diagnosed with bowel cancer roughly doubles your risk of developing bowel cancer compared with the general population.
  • Lynch syndrome and familial adenomatous polyposis (FAP) are the two most common inherited syndromes linked to bowel cancer.
  • FAP is caused by changes in the APC gene and is responsible for less than 1 per cent of all bowel cancer cases (Journal of Medical Genetics, 1999).
  • Persistent changes in bowel habits, blood in the stool, unexplained weight loss or abdominal pain call for immediate GP consultation, regardless of family history.
  • Maintaining a healthy body weight and managing BMI are crucial factors in reducing bowel cancer risk.

What counts as a family history of bowel cancer?

A first-degree relative is a parent, sibling or child. A second-degree relative is a grandparent, aunt, uncle, niece, nephew or half-sibling. Clinicians look at both when assessing family history, but a first-degree relative diagnosis generally carries more weight (Bowel Cancer Australia, 2024).

A pattern is often described as a significant family history when it includes more than one affected relative, a diagnosis before age 55, or bowel cancer and polyps appearing across more than one generation. Any of these patterns is a reason to talk to your GP about earlier or more frequent screening.

How much does family history increase bowel cancer risk?

Having one first-degree relative diagnosed with bowel cancer roughly doubles your risk of developing bowel cancer compared with the general population. Your risk increases further if more than one relative has been diagnosed, a relative was diagnosed young, or an inherited genetic condition runs in the family.

This link has been studied for decades. One of the earliest large prospective studies to establish family history as an independent risk factor followed thousands of participants over time and found a clear association between family history and colorectal cancer risk (Fuchs et al., New England Journal of Medicine, 1994). A separate population-based study reached similar conclusions using data from the Utah Population Database (Slattery & Kerber, Journal of the National Cancer Institute, 1994). Studies suggest the pattern holds regardless of which side of the family is affected (Jenkins et al., Medical Journal of Australia, 2018).

Known risk factors for developing bowel cancer

Family history is one of several known risk factors for bowel cancer. Awareness of the different risk factors helps put any single result, including a family history, into proper context (Cancer Council Australia, 2023).

Personal medical history

People with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, face an increased risk of developing bowel cancer over time, and that risk rises with the duration and extent of the disease. One meta-analysis estimated the cumulative risk of colorectal cancer in ulcerative colitis at around 2 per cent at 10 years, 8 per cent at 20 years and 18 per cent at 30 years of disease (Eaden et al., Gut, 2001). Crohn's disease affecting the colon has been associated with a similarly elevated risk (Canavan et al., Alimentary Pharmacology & Therapeutics, 2006).

A personal history of bowel cancer or adenomatous polyps (small growths called adenomas) also raises colorectal cancer risk, as does previous radiation therapy to the abdomen or pelvis.

Lifestyle factors

Several modifiable, lifestyle-related risk factors for bowel cancer sit alongside family history and personal history:

  • high consumption of red and processed meats, including bacon, ham, sausages, hot dogs and other cured or smoked meats (International Agency for Research on Cancer, 2015)
  • low fibre intake
  • physical inactivity, while regular physical activity is associated with a lower risk
  • smoking
  • drinking alcohol regularly
  • overweight or obesity

None of these factors guarantee bowel cancer will or will not develop. They combine with family history and personal history to shape your overall risk profile.

Common inherited syndromes linked to bowel cancer

A smaller number of bowel cancer cases are linked to specific hereditary conditions rather than family history and lifestyle alone. The U.S. National Cancer Institute estimates that inherited high-risk gene changes, across all known syndromes combined, account for around 5 to 6 per cent of colorectal cancer cases overall (National Cancer Institute, 2025).

Familial adenomatous polyposis (FAP)

Familial adenomatous polyposis (FAP) is caused by changes in the APC gene and is responsible for less than 1 per cent of all bowel cancer cases (Journal of Medical Genetics, 1999). It is one of several rare inherited conditions in which hundreds or thousands of polyps develop in the colon and rectum, often from the teenage years. Left unmanaged, most people with FAP will go on to develop colorectal cancer, usually at a younger age than the general population.

A related, recessively inherited condition called MUTYH-associated polyposis (MAP) causes a similar pattern of multiple colon polyps. It is caused by a gene fault in the MUTYH gene rather than APC, and is generally identified through the same genetic testing pathway used to investigate suspected FAP.

Lynch syndrome

Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common inherited syndrome linked to bowel cancer, accounting for an estimated 2 to 5 per cent of colorectal cancer cases (Centers for Disease Control and Prevention, 2026). It is caused by an inherited gene fault in one of the DNA mismatch repair (MMR) genes, MLH1, MSH2, MSH6 or PMS2, or in the EPCAM gene, which disrupts the nearby MSH2 gene (American Cancer Society, cancer.org).

People with Lynch syndrome face a higher lifetime chance of developing cancer, and not only in the bowel. Other cancers associated with Lynch syndrome include ovarian cancer, endometrial cancer, stomach cancer, urinary tract cancer, and a modestly increased risk of prostate cancer and pancreatic cancer (American Cancer Society, cancer.org). These gene changes can be passed from a parent to a child, which is why a diagnosis in one relative often prompts genetic counselling for others. Read more in our dedicated guide to Lynch syndrome.

Bowel cancer isn't only a disease of older age

Bowel cancer is most common in Australians aged 75 and over, but rates in younger adults have been rising, and around 1 in 9 cases are now diagnosed in Australians under 50 (Bowel Cancer Australia, 2024). Family history and inherited factors help explain why some people are affected at a younger age than the average age of diagnosis, which is why screening guidelines base the starting age on family history rather than age alone.

Symptoms that need immediate attention

Observing symptoms such as persistent changes in bowel habits, blood in the stool, unexplained weight loss or abdominal pain necessitates immediate consultation with a GP, whether or not you have a family history. Screening is designed to catch changes before symptoms appear, but new symptoms should never wait for a scheduled screening date.

Early detection and screening by risk category

The Cancer Council Australia Clinical Practice Guidelines, approved by the NHMRC in 2023, place people into three risk categories based on family history (Cancer Council Australia, 2023; Jenkins et al., Medical Journal of Australia, 2018):

  • Near-average risk: no first-degree relative with bowel cancer, or one first- or second-degree relative diagnosed at 55 or older.
  • Moderately increased risk: one first-degree relative diagnosed before age 55, or two first- or second-degree relatives diagnosed at any age.
  • Potentially high risk: three or more first-degree or second-degree relatives diagnosed, particularly where at least one was diagnosed before 55, or a known hereditary syndrome in the family.

Each category carries a different recommended screening test, starting age and interval. Your GP is best placed to confirm which category applies to you.

How this compares internationally: screening ages and intervals differ by country. In the United States, the American College of Gastroenterology advises that people with one first-degree relative diagnosed before 60, or two first-degree relatives diagnosed at any age, start colonoscopy at 40 or 10 years younger than the youngest affected relative, whichever comes first, repeated every five years (American College of Gastroenterology guideline, summarised in American Family Physician, 2022). The American Cancer Society's average-risk guidance starts screening at 45 (American Cancer Society, cancer.org). Australian readers should follow Cancer Council Australia's guidelines and their own GP's advice, since the recommended ages and intervals are not identical between countries.

Genetic testing and counselling

If a hereditary cancer syndrome such as Lynch syndrome or FAP is suspected, based on multiple affected relatives, early ages at diagnosis, or other cancers running in the family, your GP can refer you for genetic testing and genetic counselling. Testing looks for the specific gene fault involved, which helps clarify risk not just for you but for other family members who may also carry it. Everlab's genetic testing page explains how this type of testing generally works.

What you can do

You cannot change your family history, but several other risk factors are within your influence. Maintaining a healthy body weight and managing BMI are crucial in reducing bowel cancer risk, alongside regular physical activity, adequate fibre intake, limiting red and processed meat, moderating alcohol, and not smoking.

Sharing family history details with other family members also matters. Many Australians do not know the specifics of cancer diagnoses in their own family, including who was affected and at what age, and that detail directly affects which screening category applies. Our guide on how to reduce bowel cancer risk covers these modifiable factors in more depth.

Frequently asked questions

1. Does bowel cancer run in families?

Yes. Around 20 to 30 per cent of bowel cancer cases involve a family history, and having a first-degree relative diagnosed roughly doubles your own risk compared with the general population (Bowel Cancer Australia, 2024).

2. What's the difference between FAP and Lynch syndrome?

Familial adenomatous polyposis (FAP) is caused by changes in the APC gene and causes hundreds to thousands of colon polyps, accounting for less than 1 per cent of bowel cancer cases. Lynch syndrome is caused by a fault in a DNA mismatch repair gene or the EPCAM gene, does not typically cause large numbers of polyps, and accounts for an estimated 2 to 5 per cent of colorectal cancer cases (Centers for Disease Control and Prevention, 2026).

3. Can bowel cancer be prevented?

Bowel cancer risk can be reduced and managed, through screening, healthy body weight, physical activity and limiting known lifestyle risk factors, but no test or lifestyle change can guarantee prevention. Screening aims to find risk indicators and early changes before symptoms appear.

4. When should someone with a family history start screening?

It depends on the risk category your family history places you in. Your GP will confirm this using Cancer Council Australia's guidelines, and screening for higher-risk categories generally starts younger and more frequently than the general population schedule.

5. What symptoms shouldn't be ignored?

Persistent changes in bowel habits, blood in the stool, unexplained weight loss or abdominal pain should prompt an immediate GP visit, regardless of your age or family history.

Talking to your doctor

If you have a family history of bowel cancer, the most useful next step is a conversation with your GP about which relatives were affected and at what age, whether your family history places you in a higher-risk screening category, whether genetic counselling is appropriate, and how often you should be screened.

Everlab's health assessments look at biomarkers across a number of major chronic condition categories over time, and can support the conversation about your personal risk profile.

Disclaimer: This article is for informational purposes only and does not constitute medical advice.

References

  1. Cancer Council Australia (2023). Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. cancer.org.au
  2. Jenkins, M.A., et al. (2018). Revised Australian national guidelines for colorectal cancer screening: family history. Medical Journal of Australia, 209(10). mja.com.au
  3. Bowel Cancer Australia (2024). Non-Modifiable Risk Factors for Bowel Cancer. bowelcanceraustralia.org
  4. Eaden, J.A., Abrams, K.R., & Mayberry, J.F. (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48(4), 526–535.
  5. Canavan, C., Abrams, K.R., & Mayberry, J. (2006). Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics, 23(8), 1097–1104.
  6. International Agency for Research on Cancer (2015). IARC Monographs evaluate consumption of red meat and processed meat. World Health Organization.
  7. Fuchs, C.S., Giovannucci, E.L., Colditz, G.A., et al. (1994). A prospective study of family history and the risk of colorectal cancer. New England Journal of Medicine, 331, 1669–1674.
  8. Slattery, M.L., & Kerber, R.A. (1994). Family history of cancer and colon cancer risk: the Utah Population Database. Journal of the National Cancer Institute, 86, 1618–1626.
  9. National Cancer Institute (2025). Genetics of Colorectal Cancer (PDQ), Health Professional Version. cancer.gov
  10. American Cancer Society. Lynch Syndrome. cancer.org
  11. American Cancer Society. Colorectal Cancer Screening Guideline. cancer.org
  12. Centers for Disease Control and Prevention (2026). About Lynch Syndrome. cdc.gov
  13. American College of Gastroenterology guideline, summarised in American Family Physician (2022). Colorectal Cancer Screening: Updated Guidelines. aafp.org
  14. Genetic susceptibility to non-polyposis colorectal cancer. Journal of Medical Genetics (1999), 36(11), 801–818. pmc.ncbi.nlm.nih.gov

Dr. Steven Lu
Chief Medical Officer | MBBS (hons) | DCH FRACGP

Steven is a specialist general practitioner, preventative health consultant, medical educator, healthcare entrepreneur and co-founder of Everlab. With 15+ years of clinical experience, and driven by his passion for preventive care outcomes, Steven is dedicated to personalised and innovative approaches to enhance well-being, extend human lifespan, and improve healthspan.

Dr. Stephanie Bishop
Preventative Medicine & Gut Health Doctor | MBBS (Hons)

Clinician, medical educator, and med-tech developer with 16+ years of clinical experience and 25+ years in the health industry. Passionate about proactive longevity, preventative health, and optimising health outcomes through innovative, integrated, and holistic approaches. Experienced across rural emergency medicine, motorsport medicine, and longevity-focused care, with a research background in gastrointestinal health and a first-author publication. Dedicated to enhancing well-being, healthspan, and lifespan through evidence-based, forward-thinking healthcare solutions.

Future-proof your health.

Join 20,000+ Australians improving their health with proactive, personalised healthcare.
Book a Call

Ready to know your true fitness level?

Your VO₂ Max score is more than a number. It’s a predictor of your long-term health. Join thousands of Australians who’ve already discovered their real endurance potential.

Join today
Green star image
Rated 4.9/5 by Everlab Members
Tested with Clinical-Grade Accuracy
Supervised by Accredited Doctors
“As a triathlete, this test completely changed how I train. The insights are next-level.”
Daniel H., Sydney
Close-up of a young woman with black hair looking thoughtfully at someone.
Coronary
imaging
Advanced blood
biomarkers
3g Plant
sterols

Book a Free Discovery Call

Join 1000's of Australians improving their health with proactive, personalised healthcare.

Need more info?
Book a call

Understanding Bowel Cancer Family History: Key Risk Factors and Early Screening Explained

Learn how family history affects your bowel cancer risk, including Lynch syndrome and FAP, and when to think about screening early.

Everlab - Australia’s leading personal longevity clinic.

Learn more